Is There an Effective Treatment for Neurally Mediated Syncope?

JAMA

Volumn 289, Issue 17, 2003, Pages 2272-2275

  Kapoor, Wishwa N ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETILEFRINE; GLYCERYL TRINITRATE; ISOPRENALINE; MIDODRINE; PAROXETINE;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EDITORIAL; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HUMAN; PACEMAKER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNCOPE; TILT TABLE TEST; TREATMENT PLANNING; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; NOTE; RECURRENT DISEASE;

BRADYCARDIA; HUMANS; PACEMAKER, ARTIFICIAL; RECURRENCE; SYNCOPE, VASOVAGAL;

EID: 0038147380     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.17.2272     Document Type: Editorial

References (24)

1. Linzer M, Yang EH, Estes NA, et al. Diagnosing syncope, part 1: value of history, physical examination, and electrocardiography. Ann Intern Med. 1997;126: 989-996.
2. Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Am J Med. 1996;100:646-655.
3. Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med. 1997;29:459-466.
4. Kapoor WN, Smith M, Miller NL. Upright tilt testing in evaluating syncope. Am J Med. 1994;97:78-88.
5. Linzer M, Pritchett ELC, Pontinen M, McCarthy E, Divine GW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 1990;66:214-219.
6. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Circulation. 1999;99: 406-410.
7. Kapoor WN, Fortunato M, Hanusa BH, Schulberg HC. Psychiatric illnesses in patients with syncope. Am J Med. 1995;99:505-512.
8. Benditt DG, Ferguson DW, Grubb BP, et al. ACC expert consensus document. J Am Coll Cardiol. 1996;28:263-275.
9. Kapoor WN. Using a tilt table to evaluate syncope. Am J Med Sci. 1999;317: 110-116.
10. Kapoor WN, Brant NL. Evaluation of syncope by upright tilt testing with isoproterenol: a nonspecific test. Ann Intern Med. 1992;116:358-363.
11. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation. 1995; 92:54-58.
12. Benditt DG, Fahy GJ, Lurie KG, et al. Pharmacotherapy of neurally mediated syncope. Circulation. 1999;100:1242-1248.
13. Mahanonda N, Bhuripanyo K, Kangkagate C, et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 1995;130:1250-1253.
14. Sheldon R, Rose S, Flanagan P, et al. Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 1996;78:536-539.
15. Madrid AH, Ortega J, Rebollo GJ, et al. Lack of efficacy of atenolol for prevention of neurally mediated syncope in a highly symptomatic population. J Am Coll Cardiol. 2001;37:554-559.
16. Raviele A, Brignole M, Sutton R, et al, for the Vasovagal Syncope International Study. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. Circulation. 1999;99:1452-1457.
17. Ward CR, Gray JC, Gilroy JJ, et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45-49.
18. Perez-Lugones A, Schweikert R, Pavia S, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope. J Cardiovasc Electrophysiol. 2001;12:935-938.
19. Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope. J Am Coll Cardiol. 1999;33:1227-1230.
20. Benditt DG, Petersen M, Lurie K, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med. 1995;122:204-209.
21. Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33: 16-20.
22. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Circulation. 2000;102: 294-299.
23. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. Circulation. 2001; 104:52-57.
24. Connolly SJ, Sheldon R, Thorpe KE, et al, for the VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA. 2003;289:2224-2229.